(MENAFN- Ameliorate Digital Consultancy)
The number of R&D operations requiring in vitro testing is increasing, which is driving the expansion of the global in vitro toxicology testing market . The prohibition of animal testing is also a major factor in this market's expansion. Growing environmental concerns and the desire to make sure that no poisons via agricultural pesticides, etc. reach the environment are two additional factors driving the demand for in vitro toxicity testing. Additionally, developments in 3D cell culture are fueling this market's growth.
Request for Free Sample @
Companies Covered in This Report –
SGS S.A. Bio-Rad Laboratories, Inc. Charles River Laboratories International, Inc. Eurofins Scientific Se GE Healthcare Merck KGaA Promega Corporation Qiagen N.V. Thermo Fisher Scientific, Inc Cyprotex PLC Others
Persistence Market Research predicts that by 2022, the market for cellular assays technique type would reach a value of roughly US$ 3,700 Mn. This represents a CAGR of greater than 5% from 2017 to 2022, the assessment period. By the end of 2017, it is anticipated that the cellular assays method type segment would hold close to half of the method segment's revenue share; however, it is anticipated to see a decline in market share by 2022 compared to 2017.
Get up to 20% discount on Full Report Purchase @
Market Taxonomy : In Vitro Toxicology Testing Market
In Vitro Toxicology Testing Market By Software : Business Intelligence & Analytics Solutions, Physician Quality Reporting Solutions, Clinical Risk, Management Solutions, Provider Performance Improvement Solutions In Vitro Toxicology Testing Market By End Users : Hospitals , Ambulatory Care Centers , Payer , ACOs , Others In Vitro Toxicology Testing Market By Application : Data Management , Risk Management In Vitro Toxicology Testing Market By Delivery Mode : Cloud-based Solutions, On-premise Solutions In Vitro Toxicology Testing Market By Region : North America , Latin America , Europe , Japan , Asia Pacific excluding Japan , Middle East and Africa
Request For Customization @
Persistence Market Research predicts that by 2022, the hospitals market would have grown to a size of roughly US$ 1,200 million. This is a CAGR of roughly 12% from 2017 to 2022, the assessment period. By the end of 2017, the hospitals sector is anticipated to represent more than one-third of the end users sector's revenue share, and it is anticipated to increase its market share over 2017 by 2022.
Related Reports:
high flow oxygen therapy devices market otc scar treatment market 3d bioprinting market peripheral vascular devices market
About Us:
Persistence Market Research's Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Contact Us:
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
MENAFN26012023004660010643ID1105479061
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.